Pacific Biosciences of California, Inc. ( PACB) - Stock Earnings
PACB Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 3, 2026, midnight | — / — | — | — / — | — |
PACB Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -38.0 million USD | 38.4 million USD |
| 2025Q4 | -40.4 million USD | 44.6 million USD |
| 2026Q1 | -8.3 million USD | 37.2 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
PACB Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -306.7 million USD | 200.5 million USD |
| 2024 | -309.9 million USD | 154.0 million USD |
| 2025 | -546.4 million USD | 160.0 million USD |
| 2026 Est. | — | — |
PACB
Price: $1.36
52 week price:
Earnings Per Share: -0.41 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 5.8 million
Ebitda: -20.1 millionMarket Capitalization: 515.6 million